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It is now well established that the genomic landscape of DNA methylation (DNAm) gets altered as a function of
age, a process we here call ‘epigenetic drift’. The biological, functional, clinical and evolutionary significance of
this epigenetic drift, however, remains unclear. We here provide a brief review of epigenetic drift, focusing on the
potential implications for ageing, stem cell biology and disease risk prediction. It has been demonstrated that
epigenetic drift affects most of the genome, suggesting a global deregulation of DNAm patterns with age. A com-
ponent of this drift is tissue-specific, allowing remarkably accurate age-predictive models to be constructed.
Another component is tissue-independent, targeting stem cell differentiation pathways and affecting stem
cells, which may explain the observed decline of stem cell function with age. Age-associated increases in
DNAm target developmental genes, overlapping those associated with environmental disease risk factors
and with disease itself, notably cancer. In particular, cancers and precursor cancer lesions exhibit aggravated
age DNAm signatures. Epigenetic drift is also influenced by genetic factors. Thus, drift emerges as a promising
biomarker for premature or biological ageing, and could potentially be used in geriatrics for disease risk predic-
tion. Finally, we propose, in the context of human evolution, that epigenetic drift may represent a case of epigen-
etic thrift, or bet-hedging. In summary, this review demonstrates the growing importance of the ‘ageing
epigenome’, with potentially far-reaching implications for understanding the effect of age on stem cell function
and differentiation, as well as for disease prevention.
INTRODUCTION
DNA methylation (DNAm) is a key epigenetic mark of regula-
torypotential (1) affectingmostly (but not exclusively) cytosines
in aCpGcontext (2). Theobservation thatDNAminnormal cells
is altered as a function of age has a relatively long history, with
early studies already reporting age-associated changes affecting
a small numberof individual gene loci, notablyhighCpGdensity
promoters of important cancer genes such as IGF2 (3) andESR1
(4; see also 5,6). Global (genome-wide) hypomethylation with
age was also noted early on (7), with subsequent confirmation
in a longitudinal study of global DNAm patterns (8). It was
also observed that monozygotic (MZ) twins exhibit epigenetic
divergence inDNAmpatterns that increases with age and differ-
ences in lifestyle (9). The advent of novel biotechnologies,
allowing highly accurate assessment of DNAm levels across at
least tens of thousands of CpG sites (10), have allowed more
recent studies to test and confirm these earlier observations.
For instance, using Illumina Infinium 27K arrays (11), in
which probes map mainly to gene promoters, three separate
studies (12–14) have demonstrated that age-associated increases
inDNAmhappen preferentially at the promoters of key develop-
mental genes, notably those bivalently marked in embryonic
stem cells (15) andwhich are often alsomarked by the Polycomb
Repressive Complex (PRC2) and thus generally referred to as
PolyComb Group Targets (PCGTs) (16). Many of the bivalent
genes/PCGTs encode known tumour-suppressors and transcrip-
tion factors (TFs) necessary for differentiation. These data were
derived frommeasuring DNAm in normal tissue, specifically in
humanwhole-blood tissue (13,14), aswell as inmurine intestinal
cells (12). Two more recent studies (17,18), using the more
comprehensive and unbiased Illumina 450K arrays (19), have
further confirmed that age-associated hypermethylation
happens preferentially at high CpG density promoters, which
∗To whom correspondence should be addressed. Email: a.teschendorff@ucl.ac.uk
# The Author 2013. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/),
which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Human Molecular Genetics, 2013, Vol. 22, Review Issue 1 R7–R15
doi:10.1093/hmg/ddt375
Advance Access published on August 4, 2013
 at U
CL Library Services on February 4, 2014
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
often reside upstream of key developmental genes such as
PCGTs. These studies have also confirmed that the majority of
changes in the genome involve loss of methylation affecting
CpG sites located in low CpG density regions, in line with the
fact that most of these sites start out as methylated (17). Thus,
it would appear that the machinery responsible for maintaining
normal DNAm patterns becomes gradually deregulated with
age, leading to deviations from a normal epigenetic state, a
process we call epigenetic drift (18). Next, we briefly discuss
the potential biological, functional, clinical and evolutionary
significance of this age-associated epigenetic drift.
TISSUE-SPECIFIC AND TISSUE-INDEPENDENT
AGE-ASSOCIATED DNAm SIGNATURES
One natural question that arises in the context of the observed
epigenetic drift is whether this phenomenon is tissue-specific.
Back in 2007, Issa and co-workers (20) already noted that
age-related DNAm changes affecting certain genes were only
seen in specific tissues. In trying to fully address this question,
it is important to appreciate the complex nature of the profiled
tissues, which often encompass a variety of different cell
types. Thus, if the cellular composition of tissues alters with
age, then this could lead to age-associated DNAm signatures
which purely reflect these underlying changes in cell type.
Indeed, a number of studies have now shown that some of the
age-associated DNAm changes seen in whole-blood tissue, es-
pecially those involving hypomethylation, can be related to an
age-associated skew in blood cell-type proportions, specifically
in the relative proportion of myeloid to lymphoid cells (21–23).
This is consistent with reports of global hypomethylation as
being associated with commitment to the myeloid lineage
(24). Thus, age-associated DNAm signatures reflecting changes
in tissue composition are likely to be tissue-specific, and indeed,
these generally do not validate in other tissue types (25). There-
fore, changing cellular composition is a major confounder when
assessing DNAm changes, and, in response to this, statistical
methods aimed at dissecting this cellular heterogeneity have re-
cently emerged (22,26). Application of these methods will be
key since effect sizes associated with age and with other
EWAS phenotypes could be small (27). Indeed, these methods
have already been shown to have a dramatic impact on statistical
inference and significance estimates (28).
Interestingly, however, a number of recent studies have also
demonstrated age-associated DNAm signatures that are largely
independent of tissue type (12–14,29). For instance, a DNA
hypermethylation signature consisting of 69 CpGs mapping to
promoters of PCGTs was validated not only in whole blood
but also in normal tissue from the cervix, lung and even in
ovarian cancer cells (13). A separate study derived a similar sig-
nature, enriched for bivalently marked genes, which was then
validated in purified CD4+ T-cells and CD14+ monocytes,
thus effectively discarding changing blood cell-type compos-
ition as the underlying reason for these signatures (14). A
recentmeta-analysis focusing onbrain andblood tissue also con-
cluded that a large proportion of age-associated DNAm changes
are common to both tissue types, with important implications for
studying epigenetic effects in diseases like Alzheimer’s disease
(29). Another more recent study used a systems approach to
identify interactome hotspots of age-associated differential
methylation,whichwere found to target stem cell differentiation
pathways and to be independent of tissue type (25) (Fig. 1A).
These age-associated interactome modules, derived with Illu-
mina 27K arrays, have also been validated in data generated
using Illumina 450K arrays (Fig. 1B and C). In summary, al-
though it is hard to absolutely discard age-associated changes
in tissue composition as the underlying mechanism of these
common tissue-independent signatures, following Occam’s
Razor, the evidence does point towards the simplest explanation,
which is that gradual age-associated accumulation of DNAm
changes does occur independently of cell type.
DNAm-BASED AGE PREDICTORS
The observation that a number of age-associated DNAm signa-
tures validate consistently across so many different tissue
types is remarkable, given that analogous robust molecular sig-
natures at the copy-number, mutational or transcriptomic levels
have not been reported, or at least not at the same level of consist-
ency as seen forDNAm. In fact, ameta-analysis of age-associated
gene expression changes only reportedmarginal statistically sig-
nificant agreement across studies, although, interestingly impli-
cating genes with roles in metabolism and DNA repair (30).
Telomere attrition and other molecular features such as T-cell
DNArearrangements canpredict age, but the reportedprediction
accuracies are not high (31–34).More recently, a study reported
mosaic copy-number changeswith age, yetwhether specific age-
predictive copy-number-based signatures can be derived is
unclear (35). In contrast, at least three separate studies have
now reported DNAm -based age predictors (18,36,37). For in-
stance, in Hannum et al. (18), a DNAm-based age signature
derived in whole blood could predict the age of independent
blood samples with a median absolute deviation of only +5
years. The authors further noted that this signature was highly
correlated with age in other tissue types, but that highly accurate
absolute age estimates could be achieved only if the parameters
were retrained (18). It, therefore, seems likely that the high pre-
dictive accuracy attained by tissue-specific signatures is driven
partly, if not entirely, by tissue-specific effects.Mechanistically,
if changes in cell-type composition with age are highly certain
and tissue-specific, then this would lead to corresponding
highly accurate tissue-specific age predictors. This seems par-
ticularly relevant in the haematopoietic system where an age-
associated skew towards the myeloid lineage has been observed
(38–40). Thus, it remains to be seenwhether tissue-independent
age-associatedDNAmethylation signatures can achieve thepre-
dictive accuracy of tissue-specificDNAm signatures as reported
in, e.g., Hannum et al. (18). Irrespective of the underlying
biologicalmechanism, the high accuracy of some of theDNAm-
based age predictors derived so far already promises some excit-
ingnovel applications, for instance in forensic science it has been
suggested that they could be used to determine the approximate
age of a suspect or victim from DNA samples collected at the
crime scene (18,36). However, before this or other applications
may be considered, it will be important to validate existing and
novel DNAm-based age predictors more extensively, using
truly independent cohorts. In doing so, particular care must
also be taken in relation to technical confounding factors (e.g.
batch effects), as these could easily skewor bias results (41–43).
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Most of the age-predictive models reported so far are linear
univariate or multivariate models, which assume that the rate
at which age-associatedDNAmchanges accumulate is constant.
This ageing rate has been shown to depend on genetic factors,
and notably also on sex, with men exhibiting a faster rate (18).
It remains to be seen, however, whether the rate of change is
indeed constant, or whether instead a non-linear model could
more accurately reflect how changes accumulate with age. For
instance, a recent DNAm study performed on whole-blood
samples from a paediatric population, consisting of boys aged
between 3 and 17 years, showed that even at this young age,
DNAm changes associated with age can be detected and,
intriguingly, that these early changes account for most of the
variation seen in the adult population (44). Thus, the authors
of this study suggested a log-linear model to describe
age-associated DNAm changes. However, not being a longitu-
dinal study, and with the samples from the adult populations
coming from different cohorts and generated by independent
groups, this analysis could be subject to the usual caveats of con-
founding factors (41,43). A recent longitudinal twin study com-
paring buccal DNAm profiles of newborn twins with those at 18
months of age noted significant (3% differences at 12 months)
age-associated DNAm changes (45). This is noteworthy in
light of cross-sectional studies reporting typically 10% or at
most 25% changes in DNAm across wider age ranges encom-
passing several decades (13,18). Thus, put together, the data
from Alisch et al. (44) and Martino et al. (45) seem to suggest
that age-associated epigenetic drift kicks in immediately after
birth and may be particularly prominent during pre-puberty.
These observations are surprising, yet also very interesting
in light of studies proposing that the epigenome might be
particularly sensitive to environmental stressors (e.g. nutrient
deprivation) during pre-puberty (46,47). Thus, cumulative
age-associated exposure to environmental factors during early
life could be an important driver of epigenetic drift.
IMPLICATIONS OF AGE-ASSOCIATED DNAm
FOR AGEING, STEM CELL BIOLOGY AND
REPROGRAMMING
It is a striking observation that it is precisely the tissue-
independent age DNAm signatures that also seem to validate
in stem cell populations (13,25). For instance, an age-associated
DNAmsignature, derived fromwhole-blood tissue and enriched
for PCGTs, was validated in bone marrow-derived mesenchy-
mal stem cells (MSCs) from eight donors spanning a wide age
range (13). A similar signature was also observed to be present
in haematopoietic progenitor cells (HPCs) (48). Other tissue-
independent age signatures have also been validated in MSCs
and in HPCs (25). Thus, it would appear that the generic epigen-
etic drift observed across all tissue types may be driven by
changes in underlying long-lived stem cells, thus explaining
why these age-associated changes can be seen in differentiated
Figure 1.Tissue-independent age-associatedDNAmsignatures. (A) Three genemodules derived using Illumina 27K arrays fromwhole bloodwith promoters under-
going significant changes inDNAmwith age, demonstrating consistency across different tissue types (independentwhole-blooddata sets, brain, skin andbuccal cells)
(25). (B) FZD2/WNT-signalling interactome module from West et al. (25) with age-associated directional DNAm changes as derived from the Heyn et al.’s (17)
whole-blood data (Illumina 450K arrays). Middle panel shows the validation of the modularity, i.e. the interactome hotspot nature of the module (25) in the 450K
data set, and lower panel shows the overall consistency between the 27 and 450K sets, especially for those gene promoters undergoing significant hypermethylation
with age. (C) Validation of the directional age-associatedDNAmchanges (t-statistics) between thewhole-blood (WB) training set (27K) and the independent whole-
blood 450K data set of Hannum et al. (18).
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cell populations with a high turnover rate such as the haemato-
poietic system.
If epigenetic drift does indeed occur in stem cells, then this
drift could, over time, affect stem cell function. Supporting
this possibility, a recent bioinformatics study (25) identified
tissue-independent age-associated differential methylation
interactome hotspots, specifically targeting a number of stem
cell differentiation pathways (Fig. 1). One of these hotspots
was enriched for stem cell TFs, including UTF1, SOX8 and
SOX2, with their promoter CpGs gradually becoming hyper-
methylated with age. UTF1 is a TF necessary for the differenti-
ation of human embryonic stem cells and has also recently been
implicated as an important marker of reprogramming efficiency
(49). Another age-associated network hotspot was found to be
enriched in genes involved in WNT signalling, a pathway of
key importance for normal differentiation of stem cells (50).
Interestingly, age-associated changes in WNT-signalling activ-
ity are well documented (51,52), yet whether this is due to epi-
genetic deregulation is unclear. Interpretation is complicated
by the fact that the promoters of both negative regulators and
receptors of this pathway all become hypermethylated with
age, hence the net effect of these changes is hard to predict.
Importantly, a number of experimental studies have shown
that the age-associated DNAm changes seen in stem cells may
underlie the observed decline in stem cell function, for instance
in the case of MSCs (53) and myogenic stem cells (54). Further
important support for this hypothesis was recently provided by a
study showing thatDNAmchanges associatedwith haematopoi-
etic stem cell (HSC) ontogeny happen preferentially at PRC2
targets, and in particular at genes that would normally be
expressed in differentiated progeny (55). In fact, this study
also reported silencing (through DNA hypermethylation) of
key TFs needed for cell-lineage specification in aged HSCs,
although the overall genome-wide correlation between DNAm
and gene expression was very low, suggesting that most
DNAm changes at PRC2 targets in HSCs only affect their
transcriptional competency when passed on to downstream
progeny (55). In summary, age-associated DNAm changes in
adult stem cells possibly underpins the observed decline in
stem cell function (Fig. 2), including the observed myeloid
skewing of the ageing haematopoietic system (55) and immuno-
senescence (56).
Reprogramming of adult differentiated cells into induced
pluripotent stem cells (iPSC) is accompanied by widespread
changes in the DNAm landscape (57). Interestingly, loci under-
going age-associated DNAm changes have been observed to
overlap significantly with those undergoing changes in repro-
gramming experiments (57,58). Thus, an intriguing and exciting
possibility, suggested now by a number of studies and reviewed
inRando et al. (59), is that of ‘epigenetic rejuvenation’, whereby
age-driven accumulation of DNAm changes could be rewound
and reset to zero, thus resembling the DNAm patterns of embry-
onic stem cells.
AGE-ASSOCIATED DNAm, DISEASE RISK AND
CAUSALITY
Age-associated DNAm targeting the promoters of key tumour-
suppressor genes in normal tissue has long been noted (5,7).
Moreover, age-associated epigenetic divergence has been
observed inMZ twins, with the drift proportional to the environ-
mental divergence as measured by differences in lifestyle and
time spent apart (9), suggesting that epigenetic drift could under-
lie their observed disease discordancy (60,61). Using Illumina
beadarrays, a recent study demonstrated a highly statistically
significant overlap between genes undergoing age-associated
hypermethylation in their promoters and gene promoters under-
going hypermethylation in cancer (13), both involving preferen-
tially PRC2 targets (62–64). Furthermore, one also observes
strong overlaps of these genes with gene promoters character-
ized by DNAm changes associated with specific cancer risk
factors [e.g. smoking (65), inflammation (66–68), obesity (69)
and viral oncoprotein expression (70)]. Thus, age, cancer and
cancer risk factor DNA hypermethylation signatures all seem
commonly enriched for bivalent marks and PCGTs. However,
not all DNAm changes associated with known cancer risk
factors correlate with those seen in ageing—for instance, this
seems to be the case for sunlight/UV exposure (71). In contrast
to DNAm, it is only more recently that the age-associated muta-
tional burden in normal tissue has been assessed (72), and there-
fore it is yet unclear if age- and cancer-associated mutational
signatures overlap to the same degree as observed at the
DNAm level.
Given that (i) age-associated DNAm changes are seen in
normal tissue, (ii) that these are shared with those associated
with cancer risk factors and (iii) that age is the strongest demo-
graphic risk factor for cancer (73), it is thus entirely plausible
that these DNAm changes could predispose to cancer and thus
be used for early detection or risk prediction. Supporting this,
an age-associated DNAm signature enriched for PCGTs was
Figure 2. Putative effects of epigenetic drift. In normal ageing, whereby an indi-
vidual is not significantly exposed to disease risk factors and does not have an un-
favourable genotype, the deregulation of DNAm happens only gradually and
possibly in a linear fashion, as demonstrated by highly accurate age-predictive
linearmodels (18). In contrast, an individual exposed to risk factors, either envir-
onmental or genetic, may experience an aggravated or premature ageing profile,
characterized by an abnormally higher deregulation of DNAm patterns, increas-
ing the risk of age-related diseases like cancer or diabetes. One can further hy-
pothesize that individuals with a favourable genotype (longevity genes) and
with a healthy lifestyle may preserve amore intact epigenome and hence experi-
ence longevity. Reprogramming of aged cells into iPSCs and regeneration of dif-
ferentiated cells may provide a mechanism for epigenetic rejuvenation. In
addition to epigenetic drift, telomere shortening has been associated with
ageing, age-associated stem cell dysfunction and disease risk factors.
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found to be aggravated in intraepithelial neoplasias of the cervix,
a pre-invasive cancer lesion (13). In a subsequent study that used
a novel statistical risk-prediction algorithm based on epigenetic
variable outliers, DNAm profiles measured in cytologically
normal cervical swabs collected 3 years in advance of morpho-
logical transformation were shown to predict the future risk of
a high-grade cervical intraepithelial neoplasia (CIN2+) with a
low, yet statistically significant, AUC of approximately 0.64
(74). Importantly, the CpG sites making up this risk classifier
were shown to be associated with age in normal cervix and
other normal tissue types including blood, as well as being
highly differentially variable between individuals at different
risk of developingCIN2+ (74). Supporting this, inter-individual
variable DNAm sites have also been shown to correlate with
disease predisposition (75) and to be enriched for bivalent/
PCGT genes (76).
The overlap between DNAm changes associated with age in
normal tissue with those conferring risk of cervical cancer is in-
triguing. Interestingly, overexpression of an HPV-associated
viral oncoprotein has recently been shown to lead to widespread
DNA hypermethylation at promoters of PRC2 targets (70). This
suggests that at least someof theDNAmchanges associatedwith
the risk of cervical cancer are likely to have been caused byHPV
infection. In this regard, it is important to recall, however, that
HPV infection, although necessary, is not a sufficient factor for
cervical cancer. Hence, it is possible that age-associated epigen-
etic drift, possibly linked with a cumulative exposure to other
risk factors, contributes to disease predisposition and that
further HPV-induced epigenetic alterations then synergize with
these to allow initiation of morphological transformation (74).
The intriguing link between age-associated epigenetic drift
and the changes seen in cancer and in precursor cancer lesions
suggests a causal contributing role for DNAm in disease initi-
ation and may also extend to other diseases. Indeed, a recent
study analysing DNAm profiles of patients with Hutchinson–
Gilford Progeria and Werner Syndrome, a premature ageing
condition, concluded that DNAm changes may play a key
causal or mediating role in these diseases (77). In fact, in those
patients where the syndrome could be linked to genetic muta-
tions in known causal genes (LMNA and WRN), aberrant
DNAm profiles showed a remarkable overlap with those asso-
ciatedwith age. Interestingly, DNAmchanges, although distinct
ones,were also observed in those patients not carrying the causal
genetic mutation, suggesting that DNAm changes could play a
causal role in these subsets of patients. Further support for a
causal role of DNAm in mediating disease risk was provided
by a recent EWAS study, which identified a number of methyla-
tion quantitative trait loci associated with rheumatoid arthritis
(28). Finally, a number of epidemiological studies have also
linked epigenetic changes with overall stress levels, itself a
major risk factor for neurological diseases (78).
AGE-ASSOCIATED EPIGENETIC DRIFT: FUTURE
DIRECTIONS
It is clear that the epigenome is altered by an age-associated epi-
genetic drift, whereby normal methylation patterns become
deregulated with age. High CpG density promoters, and in
particular those mapping to developmental genes, acquire
methylation, whereas CpGs located outside these regions tend
to lose methylation with age. However, a number of key ques-
tions require urgent attention. First,what is the precise biological
mechanism (or mechanisms) leading to the deregulation of the
normal DNAm patterns? While age-dependent expression of
DNAmethyltransferase genes has been reported (79), other epi-
genetic modulators (e.g. Sirtuins) may likely play an equally or
evenmore important role (80–82).Methyl-binding domain pro-
teins (e.g.MBD4) also seem implicated inmodulating the rate of
epigenetic drift (18). More fundamentally, it has been proposed
that long-term deregulation of DNAm patterns occurs in re-
sponse to spontaneous loss of histone modifications that
happen on shorter timescales and in direct proportion to the
number of cell divisions (55,83). To elucidate the mechanisms
of regulation, it might help to investigate the degree of spatial
stochasticity of age-associated DNAm changes. Besides CpG
density, fairly little is known as to which other DNA sequence
features may effect these age-related changes. Thus, it would
be interesting to see whether age-associated methylation
changes ‘cluster’ spatially as is observed, for instance, in cancer
(84,85), or if instead they implicate a higher proportion of ‘single-
ton CpGs’, i.e. those that exhibit solitary DNAm changes and
which are, therefore, less likely to be of functional significance.
Heyn et al. (17) reported an overall loss of spatial correlations
in the DNA methylome of centenarians, yet another study did
report finding extended age-associated DMRs (aDMRs) (45).
How frequent aDMRs are and how they compare with cancer
DMRs in terms of their spatial correlative patterns remain to be
seen. The precise pattern of CG dinucleotides in sequences
affected by age-associated DNAm may also point to which epi-
genetic enzymes might be implicated (86). Alternatively, does
one observe preferential enrichment of specific TF motifs
among the sites that acquire age-associated DNAm changes,
whichwould then point to the importance of specificTFs inmedi-
ating this age-associated deregulation of DNAm patterns, ana-
logous to the TF-mediated redistribution of DNAm patterns one
observes in response to stem cell differentiation and disease
(87,88).
A second pressing question relates to the functional conse-
quences of epigenetic drift, since it would appear that the associ-
ation between age-driven DNAm and gene expression changes
is, at the very best, only marginal (18,25,55). Moreover, it
could well be that the weak association between DNAm and
gene expression observed in whole blood (18) is entirely
driven by underlying changes in blood cell-type composition
with no direct effect on cell function. Thus, it will be interesting
to perform comprehensive paired DNAm and transcriptomic
profiling of specific genes/pathways (e.g. WNT-signalling
pathway) undergoing age-associated DNAm changes in a large
number of cell-purified samples to assess the functional impact
of the epigenetic changes. It is very likely that only a very
small fraction of the age-associated epigenetic drift is of func-
tional consequence, with the few functional changes ultimately
affecting key transcriptional regulators, thus compromising
stem cell differentiation (55) or predisposing cells to neoplastic
transformation (74).
A third key outstanding question is the dissection of
age-associated DNAm changes that grow with ‘chronological
age’, reflecting the number of cell divisions of long-lived stem
cell populations, from the age-associated DNAm changes that
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may result from cumulative exposure to environmental risk
factors, as well as from the changes that may accumulate with
age in response to underlying genetic risk factors (8,18)
(Fig. 2). Two longitudinal studies, one on MZ twins (45) and
another involving families from an Icelandic cohort (8), have
shown the importance of genotype in influencing the DNAm
changes seen with age. Considerations of these separate compo-
nents thus lead to the notion of a ‘biological’ age, asmeasured by
the overall deregulation of DNAm in the genome of an individ-
ual, and which may be indicative of an overall prospective
disease risk (Fig. 2). Epigenetic studies in model organisms
where (isogenic) animals can be kept under controlled environ-
mental conditions, allowing, for instance, a sustained and con-
stant exposure to risk factors, seem key in order to help dissect
the relative contributions of the intrinsic and extrinsic ‘epigenet-
ic clocks’ in determining the biological age of the organism. Al-
though Beerman et al. (55) studied DNAm changes during HSC
ontogeny and concluded that most of the age-associated hyper-
methylation at PRC2 targets was determined by the proliferative
history of the HSCs (i.e. the intrinsic clock), these were not cells
that had been exposed to the effects of environmental risk
factors, as it might happen, for instance, under inflammatory
conditions.
A fourth key question concerns the relative importance of epi-
genetic drift in comparison with other age-associated biological
effects, most notably the well-known shortening of telomeres
with age (31,89–91). Curiously, age-associated epigenetic
drift and telomere shortening share many similar properties:
both processes are influenced by genotype (18,92,93), both
have been proposed to lead to stem cell dysfunction (55,94),
both are aggravated in men compared with women (18,91,92),
both are tissue-independent phenomena (13,95), and both have
been linked to disease, disease risk and disease risk factors
(13,18,74,96–100). For instance, a recent study reported seven
genetic variants associated with leucocyte telomere length
(LTL), with inter-individual variation in LTL being associated
with cancer and other age-related diseases (92). Thus, both
age-associated epigenetic drift and telomere shortening have
been proposed as markers of biological ageing (13,18,92,101).
In this regard, it is important to note that although epigenetic
drift seems to outperform telomere length as a predictor of
chronological age, it is the estimated deviations between pre-
dicted (i.e. biological) and chronological age that are potentially
of most interest and which may account for the observed vari-
ation in disease risk. Thus, it remains to be seen whether epigen-
etic drift or telomere attrition is a more relevant marker of
biological ageing. Matched LTL and DNAm data for MZ twin
pairs discordant for disease status or for exposure to environmen-
tal risk factors could elucidate the relative contributions of these
twobiological processes to the biological ageing anddisease risk
phenotype.
EPIGENETIC DRIFT: A CASE OF EPIGENETIC
THRIFT?
Finally, it is of interest to discuss the potential evolutionary sig-
nificance of age-associated epigenetic drift. One attractive
framework in which to interpret epigenetic drift is in the
context of evolutionary theories of ageing. One competing
theory argues that ageing emerged early in evolution as a
means of controlling population size (102,103). It is conceivable
that during times of limited resources or famine, which would
have been frequent in early living history, overpopulation
could lead to resource depletion and severe risk of mass extinc-
tion. Thus, in our ancestral species, natural ‘group’ selection
could have favoured genetic and epigenetic mechanisms that
promote ageing, with the damaging effects of thesemechanisms
only kicking in after the reproductive period, thus allowing new
improved gene pools to take over (104) and keeping overall
populations at a stable and sustainable level (102). This view-
point is supported by a related idea, grounded on evolutionary
mathematical principles, and referred to as highly optimized tol-
erance (105). This evolutionary theory proposes that biological
organisms, and multi-cellular species in particular, represent
states of highly optimized tolerance, providing robustness to
common perturbations, but simultaneously, and also inevitably,
implicating costly trade-offs, such as an increase in fragility, as
exemplified by the ageing phenotype. Thus, it is tempting to
speculate that epigenetic drift is one possible mechanism con-
tributing to the ageing phenotype (e.g. through a decline in
stem cell function) and to an associated increased risk of
disease and death (e.g. through increased predisposition to
cancer or other age-related diseases, and possibly mediated by
immunosenescence). As mentioned earlier, another mechanism
could be telomere shortening (96), and so both telomere shorten-
ing and epigenetic driftmaybe seen asprovidingan evolutionary
benefit to the species as a whole, by managing population
dynamics through ageing and increased fragility.
There are a number of other important observations which
further support a role for epigenetic drift in human evolution.
For instance, a recent study has shown that epigenetic drift
does not happen randomly in the context of the human interac-
tome, but that it preferentially affects genes of low connectivity
and centrality (106). Thus, genes carrying out integral house-
keeping and cellular functions, and which are generally of high
connectivity and centrality, appear to be more protected from
epigenetic drift. Since epigenetic drift kicks in straight after
birth (45) and is prominent even in paediatric populations (44)
(i.e. well before the reproductive period), it is tempting to specu-
late that drift affecting highly integral and essential genes would
be weeded out by natural selection. In contrast, natural selection
would not be able to efficiently weed out the epigenetic drift tar-
geting the non-essential and less integral genes, since the main
effects of drift at these genes only show up after the reproductive
age. Indeed, as argued earlier, epigenetic drift targeting non-
essential genes may even be selected for as a mechanism under-
lying ageing and increased fragility, which are necessary for
population control.
The observation that epigenetic drift is prominent in early life
(44,45), and that associated epigenetic changes could be herit-
able (107–110), further suggests that epigenetic driftmay repre-
sent another example of ‘thrift’, a termfirst coinedby JamesNeel
in the genetic context (111),wherebygenes thatwould have con-
veyed an evolutionary advantage to our ancestral species would
now lead to an opposing, apparently detrimental, effect in
today’s resource-rich society. Indeed, the genetic thrift hypoth-
esis has recently been invoked to explain the current obesity and
metabolic disease epidemics (112), according to which, genes
favouring our ancestors, for instance, in promoting fat storage
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in anticipation of possible famines, would now have detrimental
effects. Interestingly, epigenetic (or phenotype) thrift has also
been proposed as the underlying mechanism to explain the
increased incidence of diabetes and cardiovascular disease
among people born during the 1944 Dutch Winter Famine
(113,114). A compromised resource-depleted in utero environ-
ment could lead to epigenetic deregulation of metabolic genes
to promote a more favourable metabolic state, which in a food-
rich environment, however, would only be detrimental (114).
Thus, if epigenetic changes are heritable, this would allow epi-
genetic drift to quickly shape phenotypes and evolution.
In summary, it is tempting to speculate that DNAm changes
associated with epigenetic drift, which may be heritable, re-
present a case of epigenetic thrift, or perhaps even a case of
evolutionary bet-hedging (83,105,115), contributing to both
phenotypic diversity and the ageing phenotype, in a way that
optimized evolutionary adaptation and species survival in the
face of potential uncertain adversities.
Conflict of Interest statement. None declared.
FUNDING
A.E.T. is supportedbyaHellerResearchFellowship. J.W. is sup-
ported by an EPSRC/BBSRC PhD studentship awarded to
CoMPLEX. S.B. was supported by the Wellcome Trust
(WT084071) and a Royal Society Wolfson Research Merit
Award (WM100023). Funding to pay the Open Access publica-
tion charges for this article was provided by theWellcome Trust
(WT084071).
REFERENCES
1. Deaton, A.M. and Bird, A. (2011) CpG islands and the regulation of
transcription. Genes Dev., 25, 1010–1022.
2. Lister, R., Pelizzola, M., Dowen, R.H., Hawkins, R.D., Hon, G.,
Tonti-Filippini, J., Nery, J.R., Lee, L., Ye, Z., Ngo, Q.M. et al. (2009)
HumanDNAmethylomes at base resolution showwidespread epigenomic
differences. Nature, 462, 315–322.
3. Issa, J.P., Ottaviano, Y.L., Celano, P., Hamilton, S.R., Davidson, N.E. and
Baylin, S.B. (1994)Methylation of the oestrogen receptorCpG island links
ageing and neoplasia in human colon. Nat. Genet., 7, 536–540.
4. Issa, J.P., Vertino, P.M., Boehm, C.D., Newsham, I.F. and Baylin, S.B.
(1996) Switch from monoallelic to biallelic human IGF2 promoter
methylation during aging and carcinogenesis. Proc. Natl Acad. Sci. USA,
93, 11757–11762.
5. Ahuja,N., Li,Q.,Mohan,A.L.,Baylin, S.B. and Issa, J.P. (1998)Aging and
DNAmethylation in colorectalmucosa andcancer.CancerRes.,58, 5489–
5494.
6. Christensen, B.C., Houseman, E.A., Marsit, C.J., Zheng, S., Wrensch,
M.R.,Wiemels, J.L.,Nelson,H.H.,Karagas,M.R.,Padbury, J.F.,Bueno,R.
et al. (2009)Aging and environmental exposures alter tissue-specificDNA
methylation dependent upon CpG island context. PLoS Genet., 5,
e1000602.
7. Ahuja, N. and Issa, J.P. (2000) Aging, methylation and cancer. Histol.
Histopathol., 15, 835–842.
8. Bjornsson, H.T., Sigurdsson, M.I., Fallin, M.D., Irizarry, R.A., Aspelund,
T., Cui, H., Yu, W., Rongione, M.A., Ekstrom, T.J., Harris, T.B. et al.
(2008) Intra-individual changeover time inDNAmethylationwith familial
clustering. JAMA, 299, 2877–2883.
9. Fraga,M.F., Ballestar, E., Paz,M.F.,Ropero, S., Setien, F., Ballestar,M.L.,
Heine-Suner, D., Cigudosa, J.C., Urioste, M., Benitez, J. et al. (2005)
Epigenetic differences arise during the lifetime of monozygotic twins.
Proc. Natl Acad. Sci. USA, 102, 10604–10609.
10. Beck, S. (2010) Taking the measure of the methylome. Nat. Biotechnol.,
28, 1026–1028.
11. Bibikova, M. and Fan, J.B. (2010) Genome-wide DNA methylation
profiling. Wiley Interdisciplinary Reviews. Syst. Biol. Med., 2, 210–223.
12. Maegawa, S., Hinkal, G., Kim,H.S., Shen, L., Zhang, L., Zhang, J., Zhang,
N., Liang, S., Donehower, L.A. and Issa, J.P. (2010)Widespread and tissue
specific age-related DNA methylation changes in mice. Genome Res.,
20, 332–340.
13. Teschendorff, A.E., Menon, U., Gentry-Maharaj, A., Ramus, S.J.,
Weisenberger, D.J., Shen, H., Campan, M., Noushmehr, H., Bell, C.G.,
Maxwell, A.P. et al. (2010)Age-dependentDNAmethylation of genes that
are suppressed in stemcells is a hallmark of cancer.GenomeRes., 20, 440–
446.
14. Rakyan, V.K., Down, T.A.,Maslau, S., Andrew, T., Yang, T.P., Beyan, H.,
Whittaker, P., McCann, O.T., Finer, S., Valdes, A.M. et al. (2010) Human
aging-associated DNA hypermethylation occurs preferentially at bivalent
chromatin domains. Genome Res., 20, 434–439.
15. Bernstein, B.E., Mikkelsen, T.S., Xie, X., Kamal, M., Huebert, D.J., Cuff,
J., Fry, B., Meissner, A., Wernig, M., Plath, K. et al. (2006) A bivalent
chromatin structure marks key developmental genes in embryonic stem
cells. Cell, 125, 315–326.
16. Lee, T.I., Jenner, R.G., Boyer, L.A., Guenther,M.G., Levine, S.S., Kumar,
R.M., Chevalier, B., Johnstone, S.E., Cole, M.F., Isono, K. et al. (2006)
Control of developmental regulators by Polycomb in human embryonic
stem cells. Cell, 125, 301–313.
17. Heyn, H., Li, N., Ferreira, H.J., Moran, S., Pisano, D.G., Gomez, A., Diez,
J., Sanchez-Mut, J.V., Setien, F., Carmona, F.J. et al. (2012) Distinct DNA
methylomes of newborns and centenarians. Proc. Natl Acad. Sci. USA,
109, 10522–10527.
18. Hannum, G., Guinney, J., Zhao, L., Zhang, L., Hughes, G., Sadda, S.,
Klotzle, B., Bibikova, M., Fan, J.B., Gao, Y. et al. (2013) Genome-wide
methylation profiles reveal quantitative views of human aging rates.Mol.
Cell, 49, 359–367.
19. Sandoval, J., Heyn, H.A., Moran, S., Serra-Musach, J., Pujana, M.A.,
Bibikova, M. and Esteller, M. (2011) Validation of a DNA methylation
microarray for 450,000 CpG sites in the human genome. Epigenetics,
6, 692–702.
20. Kwabi-Addo,B., Chung,W., Shen, L., Ittmann,M.,Wheeler, T., Jelinek, J.
and Issa, J.P. (2007) Age-related DNA methylation changes in normal
human prostate tissues. Clin. Cancer Res., 13, 3796–3802.
21. Teschendorff,A.E.,Menon,U.,Gentry-Maharaj, A., Ramus, S.J.,Gayther,
S.A., Apostolidou, S., Jones, A., Lechner, M., Beck, S., Jacobs, I.J. et al.
(2009) An epigenetic signature in peripheral blood predicts active ovarian
cancer. PLoS One, 4, e8274.
22. Houseman, E.A., Accomando, W.P., Koestler, D.C., Christensen, B.C.,
Marsit, C.J., Nelson, H.H., Wiencke, J.K. and Kelsey, K.T. (2012) DNA
methylation arrays as surrogatemeasures of cellmixture distribution.BMC
Bioinformatics, 13, 86.
23. Langevin, S.M., Houseman, E.A., Christensen, B.C., Wiencke, J.K.,
Nelson, H.H., Karagas, M.R., Marsit, C.J. and Kelsey, K.T. (2011) The
influenceof aging, environmental exposures and local sequence features on
the variation of DNA methylation in blood. Epigenetics, 6, 908–919.
24. Ji, H., Ehrlich, L.I., Seita, J., Murakami, P., Doi, A., Lindau, P., Lee, H.,
Aryee, M.J., Irizarry, R.A., Kim, K. et al. (2010) Comprehensive
methylomemap of lineage commitment from haematopoietic progenitors.
Nature, 467, 338–342.
25. West, J., Beck, S., Wang, X. and Teschendorff, A.E. (2013) An integrative
network algorithm identifies age-associated differential methylation
interactome hotspots targeting stem-cell differentiation pathways. Sci.
Rep., 3, 1630.
26. Quon, G., Haider, S., Deshwar, A.G., Cui, A., Boutros, P.C. andMorris, Q.
(2013) Computational purification of individual tumor gene expression
profiles leads to significant improvements in prognostic prediction.
Genome Med., 5, 29.
27. Rakyan, V.K., Down, T.A., Balding, D.J. and Beck, S. (2011)
Epigenome-wide association studies for common human diseases. Nat.
Rev. Genet., 12, 529–541.
28. Liu, Y., Aryee, M.J., Padyukov, L., Fallin, M.D., Hesselberg, E.,
Runarsson, A., Reinius, L., Acevedo, N., Taub, M., Ronninger, M. et al.
(2013)Epigenome-wide association data implicateDNAmethylation as an
intermediary of genetic risk in rheumatoid arthritis. Nat. Biotechnol.,
31, 142–147.
Human Molecular Genetics, 2013, Vol. 22, Review Issue 1 R13
 at U
CL Library Services on February 4, 2014
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
29. Horvath, S., Zhang, Y., Langfelder, P., Kahn, R.S., Boks, M.P., van Eijk,
K., van den Berg, L.H. and Ophoff, R.A. (2012) Aging effects on DNA
methylation modules in human brain and blood tissue. Genome Biol.,
13, R97.
30. de Magalhaes, J.P., Curado, J. and Church, G.M. (2009) Meta-analysis of
age-relatedgene expressionprofiles identifies commonsignatures of aging.
Bioinformatics, 25, 875–881.
31. Aubert, G. and Lansdorp, P.M. (2008) Telomeres and aging.Physiol. Rev.,
88, 557–579.
32. Meissner, C. and Ritz-Timme, S. (2010) Molecular pathology and age
estimation. Forensic Sci. Int., 203, 34–43.
33. Zubakov, D., Liu, F., van Zelm, M.C., Vermeulen, J., Oostra, B.A., van
Duijn, C.M., Driessen, G.J., van Dongen, J.J., Kayser, M. and Langerak,
A.W. (2010) Estimating human age from T-cell DNA rearrangements.
Curr. Biol., 20, R970–R971.
34. Lin, J., Epel, E. and Blackburn, E. (2012) Telomeres and lifestyle factors:
roles in cellular aging.Mutat. Res., 730, 85–89.
35. Laurie,C.C.,Laurie,C.A.,Rice,K.,Doheny,K.F., Zelnick, L.R.,McHugh,
C.P.,Ling,H.,Hetrick,K.N.,Pugh,E.W.,Amos,C.et al. (2012)Detectable
clonal mosaicism from birth to old age and its relationship to cancer. Nat.
Genet., 44, 642–650.
36. Koch, C.M. and Wagner, W. (2011) Epigenetic-aging-signature to
determine age in different tissues. Aging, 3, 1018–1027.
37. Bocklandt, S., Lin, W., Sehl, M.E., Sanchez, F.J., Sinsheimer, J.S.,
Horvath, S. and Vilain, E. (2011) Epigenetic predictor of age. PLoS One,
6, e14821.
38. Pang, W.W., Price, E.A., Sahoo, D., Beerman, I., Maloney, W.J., Rossi,
D.J., Schrier, S.L. and Weissman, I.L. (2011) Human bone marrow
hematopoietic stem cells are increased in frequency and myeloid-biased
with age. Proc. Natl Acad. Sci. USA, 108, 20012–20017.
39. Rossi, D.J., Bryder, D., Zahn, J.M., Ahlenius, H., Sonu, R., Wagers, A.J.
andWeissman, I.L. (2005)Cell intrinsic alterations underlie hematopoietic
stem cell aging. Proc. Natl Acad. Sci. USA, 102, 9194–9199.
40. Beerman, I., Bhattacharya, D., Zandi, S., Sigvardsson,M.,Weissman, I.L.,
Bryder, D. andRossi, D.J. (2010) Functionally distinct hematopoietic stem
cells modulate hematopoietic lineage potential during aging by a
mechanism of clonal expansion. Proc. Natl Acad. Sci. USA, 107, 5465–
5470.
41. Leek, J.T., Scharpf,R.B.,Bravo,H.C., Simcha,D.,Langmead,B., Johnson,
W.E., Geman, D., Baggerly, K. and Irizarry, R.A. (2010) Tackling the
widespread and critical impact of batch effects in high-throughput data.
Nat. Rev. Genet., 11, 733–739.
42. Leek, J.T. and Storey, J.D. (2007) Capturing heterogeneity in gene
expression studies by surrogate variable analysis. PLoS Genet., 3, 1724–
1735.
43. Teschendorff, A.E., Zhuang, J. and Widschwendter, M. (2011)
Independent surrogate variable analysis to deconvolveconfounding factors
in large-scalemicroarrayprofilingstudies.Bioinformatics,27, 1496–1505.
44. Alisch, R.S., Barwick, B.G., Chopra, P., Myrick, L.K., Satten, G.A.,
Conneely,K.N. andWarren, S.T. (2012)Age-associatedDNAmethylation
in pediatric populations. Genome Res., 22, 623–632.
45. Martino, D., Loke, Y.J., Gordon, L., Ollikainen, M., Cruickshank, M.N.,
Saffery, R. and Craig, J.M. (2013) Longitudinal, genome-scale analysis of
DNA methylation in twins from birth to 18 months of age reveals rapid
epigenetic change in early life and pair-specific effects of discordance.
Genome Biol., 14, R42.
46. Pembrey,M.E. (2002)Time to takeepigenetic inheritance seriously.Eur. J.
Hum. Genet., 10, 669–671.
47. Pembrey, M.E., Bygren, L.O., Kaati, G., Edvinsson, S., Northstone, K.,
Sjostrom, M. and Golding, J. (2006) Sex-specific, male-line
transgenerational responses in humans.Eur. J. Hum. Genet., 14, 159–166.
48. Bocker,M.T.,Hellwig, I., Breiling,A., Eckstein, V., Ho,A.D. andLyko, F.
(2011) Genome-wide promoter DNA methylation dynamics of human
hematopoietic progenitor cells during differentiation and aging. Blood,
117, e182–e189.
49. van den Boom, V., Kooistra, S.M., Boesjes, M., Geverts, B., Houtsmuller,
A.B.,Monzen,K., Komuro, I., Essers, J., Drenth-Diephuis, L.J. andEggen,
B.J. (2007) UTF1 is a chromatin-associated protein involved in ES cell
differentiation. J. Cell Biol., 178, 913–924.
50. Baylin, S.B. and Ohm, J.E. (2006) Epigenetic gene silencing in cancer – a
mechanism for early oncogenic pathway addiction? Nat. Rev. Cancer,
6, 107–116.
51. Brack, A.S., Conboy, M.J., Roy, S., Lee, M., Kuo, C.J., Keller, C. and
Rando, T.A. (2007) Increased Wnt signaling during aging alters muscle
stem cell fate and increases fibrosis. Science, 317, 807–810.
52. Maiese, K., Li, F., Chong, Z.Z. and Shang, Y.C. (2008) TheWnt signaling
pathway: aging gracefully as a protectionist? Pharmacol. Ther., 118,
58–81.
53. Bork, S., Pfister, S.,Witt, H., Horn, P., Korn, B., Ho, A.D. andWagner,W.
(2010)DNAmethylationpatternchanges upon long-termculture and aging
of human mesenchymal stromal cells. Aging Cell, 9, 54–63.
54. Brack, A.S. and Rando, T.A. (2007) Intrinsic changes and extrinsic
influences of myogenic stem cell function during aging. Stem Cell Rev.,
3, 226–237.
55. Beerman, I.,Bock,C.,Garrison,B.S., Smith,Z.D.,Gu,H.,Meissner,A. and
Rossi, D.J. (2013) Proliferation-dependent alterations of the DNA
methylation landscape underlie hematopoietic stem cell aging. Cell Stem
Cell, 12, 413–425.
56. Grolleau-Julius, A., Ray, D. andYung, R.L. (2010) The role of epigenetics
in aging and autoimmunity. Clin. Rev. Allergy Immunol., 39, 42–50.
57. Doi, A., Park, I.H.,Wen, B., Murakami, P., Aryee, M.J., Irizarry, R., Herb,
B., Ladd-Acosta, C., Rho, J., Loewer, S. et al. (2009) Differential
methylation of tissue- and cancer-specific CpG island shores distinguishes
human induced pluripotent stem cells, embryonic stem cells and
fibroblasts. Nat. Genet., 41, 1350–1353.
58. Stricker, S.H., Feber, A., Engstrom, P.G., Caren, H., Kurian, K.M.,
Takashima, Y., Watts, C., Way, M., Dirks, P., Bertone, P. et al. (2013)
Widespread resetting of DNAmethylation in glioblastoma-initiating cells
suppresses malignant cellular behavior in a lineage-dependent manner.
Genes Dev., 27, 654–669.
59. Rando, T.A. and Chang, H.Y. (2012) Aging, rejuvenation, and epigenetic
reprogramming: resetting the aging clock. Cell, 148, 46–57.
60. Bell, J.T. and Spector, T.D. (2012) DNA methylation studies using twins:
what are they telling us? Genome Biol., 13, 172.
61. Bell, J.T., Tsai, P.C.,Yang,T.P., Pidsley,R.,Nisbet, J.,Glass,D.,Mangino,
M., Zhai, G., Zhang, F., Valdes, A. et al. (2012) Epigenome-wide scans
identify differentially methylated regions for age and age-related
phenotypes in a healthy ageing population. PLoS Genet., 8, e1002629.
62. Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G.,
Marth, C., Weisenberger, D.J., Campan, M., Young, J., Jacobs, I. et al.
(2007) Epigenetic stem cell signature in cancer.Nat. Genet., 39, 157–158.
63. Schlesinger, Y., Straussman, R., Keshet, I., Farkash, S., Hecht, M.,
Zimmerman, J., Eden, E., Yakhini, Z., Ben-Shushan, E., Reubinoff, B.E.
et al. (2007) Polycomb-mediated methylation on Lys27 of histone H3
pre-marks genes for de novo methylation in cancer. Nat. Genet., 39,
232–236.
64. Ohm, J.E., McGarvey, K.M., Yu, X., Cheng, L., Schuebel, K.E., Cope, L.,
Mohammad, H.P., Chen, W., Daniel, V.C., Yu, W. et al. (2007) A stem
cell-like chromatin patternmaypredispose tumor suppressorgenes toDNA
hypermethylation and heritable silencing. Nat. Genet., 39, 237–242.
65. Selamat, S.A., Chung,B.S.,Girard,L., Zhang,W., Zhang,Y., Campan,M.,
Siegmund, K.D., Koss, M.N., Hagen, J.A., Lam, W.L. et al. (2012)
Genome-scale analysis of DNA methylation in lung adenocarcinoma and
integration with mRNA expression. Genome Res., 22, 1197–1211.
66. Suzuki, H., Toyota, M., Kondo, Y. and Shinomura, Y. (2009)
Inflammation-related aberrant patterns ofDNAmethylation: detection and
role in epigenetic deregulation of cancer cell transcriptome.Methods Mol.
Biol., 512, 55–69.
67. Issa, J.P., Ahuja, N., Toyota,M., Bronner, M.P. and Brentnall, T.A. (2001)
Accelerated age-related CpG island methylation in ulcerative colitis.
Cancer Res., 61, 3573–3577.
68. Issa, J.P. (2011) Epigenetic variation and cellular Darwinism.Nat. Genet.,
43, 724–726.
69. Xu,X., Su, S., Barnes,V.A.,DeMiguel, C., Pollock, J., Ownby,D., Shi,H.,
Zhu, H., Snieder, H. and Wang, X. (2013) A genome-wide methylation
study on obesity: differential variability and differential methylation.
Epigenetics, 8.
70. Lechner, M., Fenton, T., West, J., Wilson, G., Feber, A., Henderson, S.,
Thirlwell, C., Dibra, H.K., Jay, A., Butcher, L. et al. (2013) Identification
and functional validation of HPV-mediated hypermethylation in head and
neck squamous cell carcinoma. Genome Med., 5, 15.
71. Gronniger,E.,Weber,B.,Heil,O., Peters,N., Stab,F.,Wenck,H.,Korn,B.,
Winnefeld, M. and Lyko, F. (2010) Aging and chronic sun exposure cause
distinct epigenetic changes in human skin. PLoS Genet., 6, e1000971.
R14 Human Molecular Genetics, 2013, Vol. 22, Review Issue 1
 at U
CL Library Services on February 4, 2014
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
72. Tomasetti, C., Vogelstein, B. and Parmigiani,G. (2013)Half ormore of the
somatic mutations in cancers of self-renewing tissues originate prior to
tumor initiation. Proc. Natl Acad. Sci. USA, 110, 1999–2004.
73. Hoeijmakers, J.H. (2009) DNA damage, aging, and cancer. N. Engl. J.
Med., 361, 1475–1485.
74. Teschendorff, A.E., Jones, A., Fiegl, H., Sargent, A., Zhuang, J.J.,
Kitchener, H.C. and Widschwendter, M. (2012) Epigenetic variability in
cells of normal cytology is associatedwith the risk of futuremorphological
transformation. Genome Med., 4, 24.
75. Rakyan, V.K., Beyan, H., Down, T.A., Hawa, M.I., Maslau, S., Aden, D.,
Daunay, A., Busato, F.,Mein, C.A.,Manfras, B. et al. (2011) Identification
of type 1 diabetes-associated DNA methylation variable positions that
precede disease diagnosis. PLoS Genet., 7, e1002300.
76. Gemma, C., Ramagopalan, S.V., Down, T.A., Beyan, H., Hawa, M.I.,
Holland, M.L., Hurd, P.J., Giovannoni, G., Leslie, R.D., Ebers, G.C. et al.
(2013) Inactive or moderately active human promoters are enriched for
inter-individual epialleles. Genome Biol., 14, R43.
77. Heyn, H., Moran, S. and Esteller, M. (2013) Aberrant DNA methylation
profiles in the premature aging disorders Hutchinson-Gilford Progeria and
Werner syndrome. Epigenetics, 8, 28–33.
78. Nestler, E.J. (2012) Epigenetics: stress makes its molecular mark. Nature,
490, 171–172.
79. Xiao, Y., Word, B., Starlard-Davenport, A., Haefele, A., Lyn-Cook, B.D.
and Hammons, G. (2008) Age and gender affect DNMT3a and DNMT3b
expression in human liver. Cell Biol. Toxicol., 24, 265–272.
80. Donadini, A., Rosano, C., Felli, L. and Ponassi,M. (2013) Human sirtuins:
an overview of an emerging drug target in age-related diseases and cancer.
Curr. Drug Targets, 14, 653–661.
81. Longo, V.D. and Kennedy, B.K. (2006) Sirtuins in aging and age-related
disease. Cell, 126, 257–268.
82. Saunders, L.R. and Verdin, E. (2007) Sirtuins: critical regulators at the
crossroads between cancer and aging. Oncogene, 26, 5489–5504.
83. Przybilla, J., Galle, J. andRohlf, T. (2012) Is adult stemcell aging driven by
conflicting modes of chromatin remodeling? BioEssays, 34, 841–848.
84. Hansen, K.D., Timp, W., Bravo, H.C., Sabunciyan, S., Langmead, B.,
McDonald, O.G.,Wen,B.,Wu,H., Liu,Y., Diep,D. et al. (2011) Increased
methylation variation in epigenetic domains across cancer types. Nat.
Genet., 43, 768–775.
85. Irizarry, R.A., Ladd-Acosta, C., Carvalho, B., Wu, H., Brandenburg, S.A.,
Jeddeloh, J.A., Wen, B. and Feinberg, A.P. (2008) Comprehensive
high-throughput arrays for relative methylation (CHARM). Genome Res.,
18, 780–790.
86. Glass, J.L., Fazzari, M.J., Ferguson-Smith, A.C. and Greally, J.M. (2009)
CGdinucleotideperiodicities recognizedby theDnmt3a-Dnmt3Lcomplex
are distinctive at retroelements and imprinted domains.Mamm. Genome,
20, 633–643.
87. Guilhamon, P., Eskandarpour, M., Halai, D., Wilson, G.A., Feber, A.,
Teschendorff, A.E., Gomez, V., Hergovich, A., Tirabosco, R., Fernanda
Amary, M. et al. (2013) Meta-analysis of IDH-mutant cancers identifies
EBF1 as an interaction partner for TET2. Nat. Commun., 4, 2166.
88. Hogart, A., Lichtenberg, J., Ajay, S.S., Anderson, S., Margulies, E.H. and
Bodine, D.M. (2012) Genome-wide DNA methylation profiles in
hematopoietic stem and progenitor cells reveal overrepresentation of ETS
transcription factor binding sites. Genome Res., 22, 1407–1418.
89. Blackburn, E.H. (1990) Cell biology: telomeres sans frontie`res. Nature,
343, 122.
90. Mitteldorf, J. (2010) The future of aging pathways to human life extension.
In Gregory M. Fahy., Michael D. West., L. Stephen Coles., Steven B.
Harris. (eds), The Future of Aging. Springer, pp. 87–126.
91. Benetos, A., Okuda, K., Lajemi,M., Kimura,M., Thomas, F., Skurnick, J.,
Labat, C., Bean, K. and Aviv, A. (2001) Telomere length as an indicator of
biological aging: the gender effect and relation with pulse pressure and
pulse wave velocity. Hypertension, 37, 381–385.
92. Codd,V.,Nelson,C.P.,Albrecht, E.,Mangino,M.,Deelen, J., Buxton, J.L.,
Hottenga, J.J., Fischer, K., Esko, T., Surakka, I. et al. (2013) Identification
of seven loci affecting mean telomere length and their association with
disease. Nat. Genet., 45, 422–427.
93. Broer, L., Codd,V., Nyholt, D.R., Deelen, J.,Mangino,M.,Willemsen,G.,
Albrecht, E., Amin, N., Beekman, M., de Geus, E.J. et al. (2013)
Meta-analysis of telomere length in 19 713 subjects reveals high
heritability, stronger maternal inheritance and a paternal age effect.Eur. J.
Hum. Genet., doi: 10.1038/ejhg.2012.303.
94. Blasco, M.A. (2007) Telomere length, stem cells and aging. Nat. Chem.
Biol., 3, 640–649.
95. Wilson, W.R., Herbert, K.E., Mistry, Y., Stevens, S.E., Patel, H.R.,
Hastings,R.A., Thompson,M.M. andWilliams,B. (2008)Blood leucocyte
telomere DNA content predicts vascular telomere DNA content in humans
with and without vascular disease. Eur. Heart J., 29, 2689–2694.
96. Blackburn,E.H. andEpel,E.S. (2012)Telomeresandadversity: too toxic to
ignore. Nature, 490, 169–171.
97. Blackburn, E.H., Greider, C.W. and Szostak, J.W. (2006) Telomeres and
telomerase: the path from maize, tetrahymena and yeast to human cancer
and aging. Nat. Med., 12, 1133–1138.
98. Petronis, A. (2010) Epigenetics as a unifying principle in the aetiology of
complex traits and diseases. Nature, 465, 721–727.
99. Huda, N., Tanaka, H., Herbert, B.S., Reed, T. and Gilley, D. (2007) Shared
environmental factors associated with telomere length maintenance in
elderly male twins. Aging Cell, 6, 709–713.
100. Valdes,A.M.,Andrew,T.,Gardner, J.P.,Kimura,M.,Oelsner,E.,Cherkas,
L.F., Aviv, A. and Spector, T.D. (2005) Obesity, cigarette smoking, and
telomere length in women. Lancet, 366, 662–664.
101. Samani, N.J. and van der Harst, P. (2008) Biological ageing and
cardiovascular disease. Heart, 94, 537–539.
102. Mitteldorf, J. (2006) Chaotic population dynamics and the evolution of
ageing. Evol. Ecol. Res., 8, 561–574.
103. Mitteldorf, J. (2010) Aging is not a process of wear and tear. Rejuvenation
Res., 13, 322–326.
104. Goldsmith, T.C. (2008) Aging, evolvability, and the individual benefit
requirement; medical implications of aging theory controversies. J. Theor.
Biol., 252, 764–768.
105. Kriete, A. (2013) Robustness and aging—a systems-level perspective.
Biosystems, 112, 37–48.
106. West, J.,Widschwendter,M.andTeschendorff,A.E. (2013)Thedistinctive
topologyof age-associated epigenetic drift in thehuman interactome.Proc.
Natl Acad. Sci. USA, in press.
107. Radford, E.J., Isganaitis, E., Jimenez-Chillaron, J., Schroeder, J., Molla,
M., Andrews, S., Didier, N., Charalambous, M., McEwen, K., Marazzi, G.
et al. (2012) An unbiased assessment of the role of imprinted genes in an
intergenerational model of developmental programming. PLoS Genet.,
8, e1002605.
108. Carone, B.R. and Rando, O.J. (2012) Rewriting the epigenome. Cell,
149, 1422–1423.
109. Carone, B.R., Fauquier, L., Habib, N., Shea, J.M., Hart, C.E., Li, R., Bock,
C., Li, C., Gu, H., Zamore, P.D. et al. (2010) Paternally induced
transgenerational environmental reprogramming of metabolic gene
expression in mammals. Cell, 143, 1084–1096.
110. Adkins, R.M., Thomas, F., Tylavsky, F.A. andKrushkal, J. (2011) Parental
ages and levels of DNA methylation in the newborn are correlated. BMC
Med. Genet., 12, 47.
111. Neel, J.V. (1962) Diabetes mellitus: a ‘thrifty’ genotype rendered
detrimental by ‘progress’? Am. J. Hum. Genet., 14, 353–362.
112. Wells, J.C. (2009) Thrift: a guide to thrifty genes, thrifty phenotypes and
thrifty norms. Int. J. Obes. (Lond.), 33, 1331–1338.
113. Hales, C.N. and Barker, D.J. (1992) Type 2 (non-insulin-dependent)
diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia, 35,
595–601.
114. Stoger, R. (2008) The thrifty epigenotype: an acquired and heritable
predisposition for obesity and diabetes? BioEssays, 30, 156–166.
115. Veening, J.W., Stewart, E.J., Berngruber, T.W., Taddei, F., Kuipers, O.P.
and Hamoen, L.W. (2008) Bet-hedging and epigenetic inheritance in
bacterial cell development. Proc. Natl Acad. Sci. USA, 105, 4393–4398.
Human Molecular Genetics, 2013, Vol. 22, Review Issue 1 R15
 at U
CL Library Services on February 4, 2014
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
